Isolated islet transplantation in experimental diabetes

Area of Science:

• Immunology
• Endocrinology
• Transplantation Biology

Background:

• Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia.
• Pancreatic islet transplantation is a potential therapeutic strategy for diabetes.
• Challenges include islet survival, function, and immune rejection.

Purpose of the Study:

• To evaluate the efficacy of isolated pancreatic islet transplantation in a rat model of diabetes.
• To assess the impact of transplantation site on islet survival and function.
• To investigate the role of immunosuppression in allogeneic islet graft acceptance and long-term function.

Main Methods:

• Pancreatic islets were isolated from inbred rats using collagenase digestion.
• Islets were transplanted into streptozotocin-induced diabetic recipient rats via the portal venous system.
• Immunosuppression was achieved using antilymphocyte serum (ALS) for allogeneic transplantations.
• Diabetic state was assessed by serum glucose, urinary output, weight gain, and glucose tolerance tests.

Main Results:

• Intraportal transplantation of isolated islets completely reversed the diabetic state in recipients.
• Transplantation to other sites resulted in suboptimal islet survival and function.
• Allogeneic islets survived and functioned long-term under ALS immunosuppression.
• Recipients developed tolerance to allografts after ALS treatment.
• Transplanted islets prevented the development of diabetic renal and ophthalmic complications.

Conclusions:

• Intraportal transplantation of isolated pancreatic islets is a highly effective treatment for diabetes in rats.
• Antilymphocyte serum (ALS) facilitates long-term survival and function of allogeneic islet grafts and induces tolerance.
• Islet transplantation can prevent secondary diabetic complications, highlighting its therapeutic potential.